Point mutations in the 5′UTR of ANKRD26 have shown to result in familial thrombocytopenia 2 and leukemia predisposition, mainly mediated by the derepression of ANKRD26 due to insufficient RUNX1/FLI1 complex binding. The gene discussed is RUNX1; the disease is leukemia.